Published in Science on December 19, 2002
Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med (2005) 2.67
Immune response to biologic scaffold materials. Semin Immunol (2008) 2.62
Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci U S A (2011) 2.61
Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A (2004) 2.54
The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta (2007) 2.34
Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation. PLoS Biol (2008) 2.08
Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci U S A (2007) 1.80
Hepatic function after genetically engineered pig liver transplantation in baboons. Transplantation (2010) 1.64
Current advances and travails in islet transplantation. Diabetes (2009) 1.63
Meta-analysis of the independent and cumulative effects of multiple genetic modifications on pig lung xenograft performance during ex vivo perfusion with human blood. Xenotransplantation (2014) 1.53
Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol (2010) 1.52
The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation (2009) 1.47
Functionally important glycosyltransferase gain and loss during catarrhine primate emergence. Proc Natl Acad Sci U S A (2006) 1.46
Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol (2008) 1.36
Precision editing of large animal genomes. Adv Genet (2012) 1.34
Transgene expression is associated with copy number and cytomegalovirus promoter methylation in transgenic pigs. PLoS One (2009) 1.27
Clinical islet xenotransplantation: how close are we? Diabetes (2012) 1.26
Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant (2010) 1.21
Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation. J Thorac Cardiovasc Surg (2014) 1.21
Coagulation dysregulation as a barrier to xenotransplantation in the primate. Transpl Immunol (2008) 1.17
Current status of xenotransplantation and prospects for clinical application. Xenotransplantation (2009) 1.15
A pig model of the human gastrointestinal tract. Gut Microbes (2013) 1.15
Completion of the swine genome will simplify the production of swine as a large animal biomedical model. BMC Med Genomics (2012) 1.14
Xenotransplantation--the future of corneal transplantation? Cornea (2011) 1.10
Rejection of cardiac xenografts transplanted from alpha1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons. Am J Transplant (2008) 1.08
Creating genetically modified pigs by using nuclear transfer. Reprod Biol Endocrinol (2003) 1.08
Current status of islet cell transplantation. J Hepatobiliary Pancreat Surg (2008) 1.07
Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07
Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerate. Reprod Biol Endocrinol (2003) 1.07
Costimulation blockade in pig artery patch xenotransplantation - a simple model to monitor the adaptive immune response in nonhuman primates. Xenotransplantation (2012) 1.06
Highly efficient generation of GGTA1 biallelic knockout inbred mini-pigs with TALENs. PLoS One (2013) 1.05
Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits. Immunology (2013) 1.04
Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts. Transplantation (2012) 1.04
Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literature. Xenotransplantation (2014) 1.04
Pig-to-baboon heterotopic heart transplantation--exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens. Xenotransplantation (2015) 1.04
Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model. Xenotransplantation (2013) 1.02
The piglet as a model for B cell and immune system development. Vet Immunol Immunopathol (2008) 1.02
Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells. Transplantation (2008) 1.01
Initial in vitro investigation of the human immune response to corneal cells from genetically engineered pigs. Invest Ophthalmol Vis Sci (2011) 1.01
Genetically engineered pig models for human diseases. Annu Rev Anim Biosci (2013) 1.01
Systemic inflammation in xenograft recipients precedes activation of coagulation. Xenotransplantation (2014) 1.01
Overcoming the barriers to xenotransplantation: prospects for the future. Expert Rev Clin Immunol (2010) 0.99
Cloning and expression of porcine β1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen. Xenotransplantation (2014) 0.98
Xenotransplantation: immunological hurdles and progress toward tolerance. Immunol Rev (2014) 0.97
Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin Microbiol Rev (2012) 0.97
Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. J Immunol (2013) 0.96
Comparison of hematologic, biochemical, and coagulation parameters in α1,3-galactosyltransferase gene-knockout pigs, wild-type pigs, and four primate species. Xenotransplantation (2012) 0.96
Pig-to-monkey islet xenotransplantation using multi-transgenic pigs. Am J Transplant (2014) 0.96
Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses. Transplantation (2008) 0.95
Absence of Gal epitope prolongs survival of swine lungs in an ex vivo model of hyperacute rejection. Xenotransplantation (2011) 0.95
Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigs. Transpl Immunol (2015) 0.95
Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit? Transplantation (2009) 0.95
Cardiac xenotransplantation: progress and challenges. Curr Opin Organ Transplant (2012) 0.94
Pigs taking wing with transposons and recombinases. Genome Biol (2007) 0.94
The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation. J Biomed Res (2013) 0.93
The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93
Porcine cytomegalovirus infection is associated with early rejection of kidney grafts in a pig to baboon xenotransplantation model. Transplantation (2014) 0.92
Relative efficiency of porcine and human cytotoxic T-lymphocyte antigen 4 immunoglobulin in inhibiting human CD4+ T-cell responses co-stimulated by porcine and human B7 molecules. Immunology (2011) 0.92
Expression of human CD46 modulates inflammation associated with GalTKO lung xenograft injury. Am J Transplant (2014) 0.92
A brief history of cross-species organ transplantation. Proc (Bayl Univ Med Cent) (2012) 0.91
Genetic manipulation in pigs. Curr Opin Organ Transplant (2009) 0.90
Are there advantages in the use of specific pathogen-free baboons in pig organ xenotransplantation models? Xenotransplantation (2014) 0.90
Functional tissue engineering of ligament healing. Sports Med Arthrosc Rehabil Ther Technol (2010) 0.89
The anti-non-gal xenoantibody response to xenoantigens on gal knockout pig cells is encoded by a restricted number of germline progenitors. Am J Transplant (2008) 0.89
Pathologic characteristics of transplanted kidney xenografts. J Am Soc Nephrol (2011) 0.89
Antibody-mediated xenograft injury: mechanisms and protective strategies. Transpl Immunol (2009) 0.89
New concepts of immune modulation in xenotransplantation. Transplantation (2013) 0.89
Handmade cloned transgenic piglets expressing the nematode fat-1 gene. Cell Reprogram (2012) 0.89
Kidney xenotransplantation. Kidney Int (2013) 0.88
Therapeutic issues in the treatment of vascularized xenotransplants using gal-knockout donors in nonhuman primates. Curr Opin Organ Transplant (2011) 0.88
Intracellularly expressed single-domain antibody against p15 matrix protein prevents the production of porcine retroviruses. J Virol (2003) 0.88
Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases. Hum Genet (2016) 0.88
Genetically-engineered pig-to-baboon liver xenotransplantation: histopathology of xenografts and native organs. PLoS One (2012) 0.88
Electroporation advances in large animals. Curr Gene Ther (2009) 0.87
The role of genetically engineered pigs in xenotransplantation research. J Pathol (2015) 0.87
Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement pathway-regulatory protein. Xenotransplantation (2015) 0.87
The effect of Gal expression on pig cells on the human T-cell xenoresponse. Xenotransplantation (2012) 0.87
Highly efficient CRISPR/Cas9-mediated transgene knockin at the H11 locus in pigs. Sci Rep (2015) 0.86
Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells. J Thromb Haemost (2010) 0.86
Human T-cell proliferation in response to thrombin-activated GTKO pig endothelial cells. Xenotransplantation (2012) 0.85
Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties. Cytotherapy (2012) 0.85
Porcine sialoadhesin: a newly identified xenogeneic innate immune receptor. Am J Transplant (2012) 0.85
T-cell-based immunosuppressive therapy inhibits the development of natural antibodies in infant baboons. Transplantation (2012) 0.85
Achieving tolerance in pig-to-primate xenotransplantation: reality or fantasy. Transpl Immunol (2008) 0.84
Specific genetic modifications of domestic animals by gene targeting and animal cloning. Reprod Biol Endocrinol (2003) 0.84
Cytokine secretion depends on Galalpha(1,3)Gal expression in a pig-to-human whole blood model. J Immunol (2008) 0.84
Xenoantibody response to porcine islet cell transplantation using GTKO, CD55, CD59, and fucosyltransferase multiple transgenic donors. Xenotransplantation (2014) 0.83
New life for pig-to-human transplants. Nature (2015) 0.83
Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope. J Virol (2004) 0.83
Removal of alpha-Gal epitopes from porcine aortic valve and pericardium using recombinant human alpha galactosidase A. J Korean Med Sci (2009) 0.83
Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation. J Transplant (2011) 0.83
Differential resistance to cell entry by porcine endogenous retrovirus subgroup A in rodent species. Retrovirology (2007) 0.83
CD47 in xenograft rejection and tolerance induction. Xenotransplantation (2010) 0.83
Anti-gal antibodies in α1,3-galactosyltransferase gene-knockout pigs. Xenotransplantation (2012) 0.82
Creation of non-human primate neurogenetic disease models by gene targeting and nuclear transfer. Reprod Biol Endocrinol (2004) 0.82
Glucose metabolism in pigs expressing human genes under an insulin promoter. Xenotransplantation (2014) 0.82
Immunobiological barriers to xenotransplantation. Int J Surg (2015) 0.82
Organ transplantation: a practical triumph and epistemologic collapse. Proc Am Philos Soc (2003) 0.82
Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs. Xenotransplantation (2016) 0.82
Immunobiology of liver xenotransplantation. Expert Rev Clin Immunol (2012) 0.81
Rates of spontaneous mutation. Genetics (1998) 14.89
Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science (2002) 5.64
Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol (2002) 4.82
Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem (1988) 3.34
Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc (1992) 1.99
Bovine alpha1,3-galactosyltransferase catalytic domain structure and its relationship with ABO histo-blood group and glycosphingolipid glycosyltransferases. EMBO J (2001) 1.62
The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile. J Clin Invest (1995) 1.51
Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Gal alpha 1-3Gal beta 1-4GlcNAc sequences. Arch Biochem Biophys (1987) 1.51
The α-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation. Biochimie (2001) 1.48
The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation (1996) 1.45
Genetically engineered pigs. Lancet (1993) 1.42
Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem (2001) 1.18
Prospects for xenotransplantation. Curr Opin Immunol (2000) 1.16
Differential expression of alpha-GAL epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on pig and mouse organs. Transplantation (2000) 1.09
Recent advances in xenotransplantation. Curr Opin Immunol (1999) 1.04
Actin and lamin comprised filaments in the nuclei of Chinese hamster ovary cells affected with Clostridium difficile enterotoxin A. Cytobios (1990) 0.99
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology (2004) 6.98
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med (2006) 6.31
Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant (2005) 5.87
Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol (2002) 4.82
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09
On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. Am J Hum Genet (2008) 3.95
Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic (2002) 3.39
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology (2007) 3.18
Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol (2006) 3.07
Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev (2009) 3.02
Screen and clean: a tool for identifying interactions in genome-wide association studies. Genet Epidemiol (2010) 2.70
Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med (2005) 2.67
PDGF signalling controls age-dependent proliferation in pancreatic β-cells. Nature (2011) 2.53
VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION. Surg Forum (1983) 2.30
A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol (2007) 2.23
THE USE OF COMBINED PRESERVATION TECHNIQUES FOR EXTENDED STORAGE OF ORTHOTOPIC LIVER HOMOGRAFTS. Surg Gynecol Obstet (1968) 2.20
Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes (2004) 2.16
Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol (2005) 2.14
Factors associated with islet yield and insulin independence after total pancreatectomy and islet cell autotransplantation in patients with chronic pancreatitis utilizing off-site islet isolation: Cleveland Clinic experience. J Clin Endocrinol Metab (2015) 2.14
Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology (2006) 2.08
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl (2002) 2.07
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93
Clinical xenotransplantation: the next medical revolution? Lancet (2011) 1.84
Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1. Diabetes (2004) 1.81
The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med (2005) 1.75
Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. Clin Transplant (1989) 1.74
Complications of right lobe living donor liver transplantation. J Hepatol (2009) 1.73
Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT. Dev Cell (2012) 1.72
Thymus-specific deletion of insulin induces autoimmune diabetes. EMBO J (2009) 1.70
Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J Biol Chem (2009) 1.69
Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care (2011) 1.65
Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pediatr Diabetes (2005) 1.64
Monocytes are progressively activated in the circulation of pregnant women. J Leukoc Biol (2002) 1.63
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation (2008) 1.62
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61
A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells. Blood (2011) 1.60
EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION. Surg Forum (1986) 1.59
HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J Immunol (2006) 1.58
Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution. Blood (2011) 1.55
ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology (2002) 1.54
Meta-analysis of the independent and cumulative effects of multiple genetic modifications on pig lung xenograft performance during ex vivo perfusion with human blood. Xenotransplantation (2014) 1.53
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52
Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyond. Pediatr Diabetes (2008) 1.50
Sirolimus is associated with reduced islet engraftment and impaired beta-cell function. Diabetes (2006) 1.49
Enhancing alloreactivity does not restore GVHD induction but augments skin graft rejection by CD4⁺ effector memory T cells. Eur J Immunol (2011) 1.49
Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant (2006) 1.48
Functionally important glycosyltransferase gain and loss during catarrhine primate emergence. Proc Natl Acad Sci U S A (2006) 1.46
Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes. Diabetes (2006) 1.45
Optimization of square-wave electroporation for transfection of porcine fetal fibroblasts. Transgenic Res (2009) 1.44
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42
Identification of novel IGRP epitopes targeted in type 1 diabetes patients. Clin Immunol (2008) 1.38
SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum (1967) 1.37
Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36
Gene targeting with zinc finger nucleases to produce cloned eGFP knockout pigs. Mol Reprod Dev (2011) 1.36
MELD and prediction of post-liver transplantation survival. Liver Transpl (2006) 1.33
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA (2012) 1.33
Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development. Lab Invest (2008) 1.32
Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. Mol Cancer Ther (2009) 1.31
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Wnt'er in liver: expression of Wnt and frizzled genes in mouse. Hepatology (2007) 1.27
Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice. Diabetes (2005) 1.27
Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells. Blood (2008) 1.27
Clinical islet xenotransplantation: how close are we? Diabetes (2012) 1.26
Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes. Pancreas (2006) 1.25
Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24
Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl (1989) 1.24
Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes (2002) 1.23
Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLoS Comput Biol (2011) 1.21
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (2002) 1.21
Azithromycin-induced intrahepatic cholestasis. Dig Dis Sci (2002) 1.20